Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Loss Before Income Tax Domestic And Foreign [Line Items]
Loss from continuing operations before income taxes	$ 6,202,374	$ 5,287,094
Domestic Tax Authority [Member]
Income Loss Before Income Tax Domestic And Foreign [Line Items]
Loss from continuing operations before income taxes	5,442,499	636,651
Foreign Tax Authority [Member]
Income Loss Before Income Tax Domestic And Foreign [Line Items]
Loss from continuing operations before income taxes	$ 759,875	$ 4,650,443